Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Summit Therapeutics
Fierce Pharma
Akeso, Summit's PD-1xVEGF drug meets OS goal for the first time
Akeso and Summit Therapeutics’ PD-1xVEGF bispecific antibody ivonescimab has shown for the first time that it can extend patients’ lives.
Angus Liu
Aug 26, 2025 11:36am
Fierce Pharma
Summit in high-stakes deal talks with AstraZeneca: Bloomberg
Jul 7, 2025 10:45am
Former FDA deputy joins AI biotech's board—Chutes & Ladders
Mar 21, 2025 8:30am
Pfizer to test Summit's white-hot bispecific with ADCs
Feb 24, 2025 9:17am
Akeso's bispecific notches ph. 3 victory against gastric cancer
Nov 7, 2023 10:50am
Google DeepMind vet to join GSK—Chutes & Ladders
Oct 20, 2023 9:30am
